arrow
H

Hana M. El Sahly

baylor college of medicine
H指数:35
被引数:6,497

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Zika Virus Neutralizing Antibody Responses Elicited by Vaccination or Infection

疫苗或感染诱发的寨卡病毒中和抗体反应

2025-12-010
PRE
A Test-Negative Design for Immune Correlates Approximates a Traditional Exposure-Proximal Design but Requires Far Fewer Blood Samples

一种免疫相关性研究的测试阴性设计近似于传统的暴露邻近设计,但需要远少量的血液样本。

2025-12-010
PRE
Evaluation of the safety and immunogenicity of two fractional intradermal regimens of MVA-BN compared to standard dose vaccination

评估两种分数剂量皮内接种MVA-BN方案与标准剂量疫苗接种的安全性和免疫原性比较

Vaccine
IF3.5
2025-11-290
PRE
Validating and leveraging non-SARS-CoV-2 respiratory infection as a negative control outcome in a phase 3 COVID-19 vaccine trial with extended observational follow-up

验证并利用非SARS-CoV-2呼吸道感染作为一项扩展观察性随访的III期COVID-19疫苗试验中的阴性对照结局。

2025-09-010
PRE
The DESTINIES Study: an online Delphi study to build international consensus on the medical conditions and procedures that confer immunosuppression and their respective COVID-19 risk profiles

DESTINIES研究:一项在线德尔菲研究,旨在就赋予免疫抑制的医疗条件和程序及其各自的COVID-19风险特征建立国际共识

2025-05-010
OAAI
A phase I study of the safety, reactogenicity and immunogenicity of two quadrivalent seasonal influenza vaccines (Fluzone® or Flublok®) with or without one of two adjuvants (AF03 or Advax-CpG55.2) in healthy adults 18-45 years of age

一项关于两种四价季节性流感疫苗(Fluzone®或Flublok®)在18-45岁健康成年人中,单独使用或与两种佐剂(AF03或Advax-CpG55.2)联合使用时的安全性、反应原性和免疫原性的I期研究

VACCINE
IF3.5
2025-04-010
PRE
Anti-neuraminidase and anti-hemagglutinin stalk responses to different influenza a(H7N9) vaccine regimens

抗神经氨酸酶和抗血凝素stalk对不同流感A(H7N9)疫苗方案的反应

VACCINE
IF3.5
2025-02-010
PRE
Who to Boost When: The Effect of Age and Dosing Interval on Delta and Omicron COVID-19 Incidence in the Open-label Phase of the COVE Trial

在COVE试验的开放标签阶段,年龄和给药间隔对Delta和Omicron新型冠状病毒肺炎发病率的影响

2024-11-250
OA
Relative Effectiveness and Immunogenicity of Quadrivalent Recombinant Influenza Vaccine Versus Egg-Based Inactivated Influenza Vaccine Among Adults Aged 18-64 Years: Results and Experience From a Randomized, Double-Blind Trial

在18-64岁的成年人中,四价重组流感疫苗与基于鸡蛋的灭活流感疫苗的相对有效性和免疫原性: 一项随机,双盲试验的结果和经验

2024-09-261
OA
Omicron COVID-19 immune correlates analysis of a third dose of mRNA-1273 in the COVE trial

COVE试验中第三剂mRNA-1273的Omicron新型冠状病毒肺炎免疫相关分析

2024-09-110
OAAI
SARS-CoV-2 RNA and Nucleocapsid Antigen Are Blood Biomarkers Associated With Severe Disease Outcomes That Improve in Response to Remdesivir

SARS-CoV-2 RNA和核衣壳抗原是与严重疾病结局相关的血液生物标志物,对Remdesivir的反应有所改善

2024-04-243
OA